Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hemotapoietic products

Annals of Oncology

Volumn 13, Issue 3, 2002, Pages 422-429

  Silva, A L ^a   Tome M J ^a   Correia, A E ^a   Passos Coelho, J L ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Breast cancer; Mammaglobin; Minimal residual disease

Indexed keywords

MAMMAGLOBIN; MESSENGER RNA; MOLECULAR MARKER; TUMOR MARKER; UNCLASSIFIED DRUG; UTEROGLOBIN; RNA; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; BREAST; BREAST CANCER; BREAST METASTASIS; CANCER CELL CULTURE; CONTAMINATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; OCCULT CANCER; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; THROMBOCYTOPENIA; BLOOD; BREAST TUMOR; CELL CULTURE; COMPARATIVE STUDY; FEMALE; GENETICS; MIDDLE AGED; TUMOR EMBOLISM;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 0036018903     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf107     Document Type: Article

References (24)

1. Cancer Statistics, 1996
2. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
3. Detection and clinical importance of micrometastatic disease
4. Detection of minimal disease in patients with solid tumors
5. Utilization of polymerase chain reaction technology in the detection of solid tumors
6. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methods
7. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
8. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
9. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes
10. CK20 gene expression: Technical limits for the detection of circulating tumor cells
11. Cytoketatin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues
12. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer
13. Mammaglobin expression in primary, metastatic, and occult breast cancer
14. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA
15. BCR-ABL, ABL-BCR, BCR and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia
16. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13
17. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation
18. Relapse of chronic myeloid leukemia after allogenic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse
19. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RAR α fusion gene in patients with acute promyelocytic leukemia enroled in the GIMEMA-AIEOP multicenter 'AIDA' trial
20. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow
21. Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte macrophage colony-stimulating factor
22. Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor
23. Reverse transcription/polymerase chain reaction (RT/PCR) amplification of a very small number of transcripts: The risk in misinterpreting negative results
24. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors